
Joseph C. Papa
Director · Candel Therapeutics, Inc.
- 2025
- Oct 2, 2026
- 12
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Joseph C. Papa files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Paul Peter Tak - $3.16M in CADL purchases and sales in the last 12 months
- Paul B. Manning - $3.00M in CADL purchases and sales in the last 12 months
- Francesca Barone - $236K in CADL purchases and sales in the last 12 months
- Seshu Tyagarajan - $154K in CADL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Joseph C. Papa?
Joseph C. Papa is a corporate insider, tracked as Director of Candel Therapeutics, Inc. (CADL). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Joseph C. Papa submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Joseph C. Papa been buying or selling stock?
Recorded transactions: 1 open-market purchase ($350K) and 0 open-market sales across all tracked filings.